Awareness of J&J lawsuits affects the company stocks

As J&J is vigorously defending itself in the second ongoing mesothelioma trial allegedly linked to its Talcum Powder product, the company witnessed a dip in its stock value by 5 % earlier this month attributed to the unveiling of documents at the court that revealed the talc powder contained asbestos and other cancer-causing heavy metals.

The giant conglomerate is also facing thousands of ovarian cancer lawsuits filed on behalf of women who allegedly developed ovarian cancer linked to the use of Talcum Powder for feminine hygiene purposes.


Recent News